Rock Springs Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $23.2M | Sell |
|
|||||
|
2023
Q4 | $113M | Buy |
|
|||||
|
2023
Q3 | $55.2M | Buy |
|
|||||
|
2023
Q2 | $79.9M | Hold |
|
|||||
|
2023
Q1 | $61.3M | Buy |
|
|||||
|
2022
Q4 | $79.1M | Buy |
|
|||||
|
2022
Q3 | $70.6M | Buy |
|
|||||
|
2022
Q2 | $46.7M | Buy |
|
|||||
|
2022
Q1 | $60.3M | Buy |
|
|||||
|
2021
Q4 | $53.4M | Buy |
|
|||||
|
2021
Q3 | $47.2M | Buy |
|
|||||
|
2021
Q2 | $26.1M | Buy |
|
|||||
|
2021
Q1 | $13.8M | Buy |
|
|||||
|
2020
Q4 | $16.6M | Buy |
|